Seems that over half retail owners did not subscribe to more shares. Not a good look. Where to this morning.$22?http://www.businessspectator.com.au/bs.nsf/Article/Leighton-share-sale-flops-report-pd20110511-GRRMZ?opendocument&src=idp
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025